Investment
Features
FeesSafety
Academy
More
Pluang+

GFL Environmental declares Q3 2026 cash dividend of US$0.0169 per share, payable Oct 30.

Company Fundamentals
29 Sep 2026
PRNewsWire
View Source
Bullish
GFL Environmental declares Q3 2026 cash dividend of US$0.0169 per share, payable Oct 30.

GFL Environmental Inc. announced a cash dividend of US$0.0169 per share for the third quarter of 2026. The dividend will be paid on October 30, 2026, to shareholders registered by October 14, 2026. This dividend is designated as an eligible dividend under Canadian tax law. GFL is a major North American environmental services company with over 17,000 employees, operating in Canada and 19 U.S. states. The company noted that future dividends depend on the Board's discretion and may be subject to change.

GFL Environmental Inc. announced a quarterly cash dividend of US$0.0169 per share for Q3 2026, payable on October 30, 2026. For readers following Industrials-sector US stocks, here is Pluang's market snapshot as of Sep 29, 2026 17:31 WIB: out of 93 priced stocks, 55 rose and 33 fell. Notable movers include EOSE at USD 3.10 with a 0.98% increase and 100% buy order activity, AXON at USD 420.86 down 0.92% with 100% buy order activity, and FLUX at USD 0.46 down 0.81% with 79% sell order activity.

More News

PUMP token jumps 4.03% in an hour, reaching $0.005238 and $2.34B market cap

PUMP token jumps 4.03% in an hour, reaching $0.005238 and $2.34B market cap

The cryptocurrency token PUMP rose 4.03% within one hour to $0.005238 on September 29, extending its 24-hour gain to 4.32%. This surge pushed its market capitalization to approximately $2.34 billion, ranking it 48th among crypto assets by market cap....

Market News
Bullish
4 hours ago
Filament ships psilocybin drug PEX010 for Phase 2 PTSD trial at University of Calgary

Filament ships psilocybin drug PEX010 for Phase 2 PTSD trial at University of Calgary

Filament Health, a subsidiary of Rhelion Life Sciences, has shipped its botanical psilocybin drug candidate PEX010 to the University of Calgary for a Phase 2 clinical trial called PsiPTSD. This trial will test psilocybin-assisted therapy for chronic ...

Market News
Bullish
4 hours ago
iQSTEL grows telecom platform to $0.5bn revenue but remains unprofitable, relying on equity funding.

iQSTEL grows telecom platform to $0.5bn revenue but remains unprofitable, relying on equity funding.

iQSTEL has developed a global telecommunications platform offering international voice and data termination services. Despite rapid growth to a revenue run rate exceeding $0.5 billion through acquisitions and organic expansion, the company has yet to...

Market News
Neutral
4 hours ago
Atlas Salt's Black Bay nepheline syenite shows ultra-low iron after German test, advancing drilling plans.

Atlas Salt's Black Bay nepheline syenite shows ultra-low iron after German test, advancing drilling plans.

Atlas Salt announced successful beneficiation test results on nepheline syenite from its Black Bay property, reducing iron oxide impurities to 0.01-0.03%, well below industry limits, using simple magnetic separation. This high-purity product meets sp...

Market News
Bullish
4 hours ago
AAVE token jumps 15% as Aave plans token burn in Aavenomics 3.0 update

AAVE token jumps 15% as Aave plans token burn in Aavenomics 3.0 update

AAVE, the native token of the decentralized lending platform Aave, surged over 15% in 24 hours, reaching above $170 for the first time since January 19. This sharp rise followed the announcement by Aave's founder, Stani Kulechov, that the project is ...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App